Blocking the mTOR-Myc-DC-SIGN axis in acinar cells might be a therapeutic intervention approach by balancing local CD4+ T-cell-mediated pro-inflammatory and anti-inflammatory responses during AP. This evidence concerns the gene CD209 and alkaline phosphatase measurement.